Switch to
More onapp

How to use scorecard? Learn more

Kimia Biosciences Ltd

KIMIABL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹235 cr, stock is ranked 2,373
High RiskStock is 3.97x as volatile as Nifty
50.000.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹235 cr, stock is ranked 2,373
High RiskStock is 3.97x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
81.80
PB RatioPB Ratio
43.14
Dividend YieldDiv. Yield
Sector PESector PE
51.90
Sector PBSector PB
6.61
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The company makes bulk drug intermediates. It manufactures bulk drugs intermediates for Indian pharmaceutical companies on contract manufacturing basis. It also offers finish goods and fine chemicals.

Financial TrendFinancial statements 

2021202220232024135.17125.83129.73106.525.10-3.70-9.35-5.30
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

AGM/EGM 
Announced OnDec 7, 2024

Kimia Biosciences Ltd - 530313 - 31St Annual General Meeting ('AGM') Of The Company Is Scheduled To Be Held On Monday, December 30, 2024 At 04.00 Pm (IST) Through Video Conferencing/ Other Audio Visual Means ('VC/OAVM') | Download

Kimia Biosciences Ltd - 530313 - 31St Annual General Meeting ('AGM') Of The Company Is Scheduled To Be Held On Monday, December 30, 2024 At 04.00 Pm (IST) Through Video Conferencing/ Other Audio Visual Means ('VC/OAVM') | Download

Company Update 
Announced OnDec 6, 2024

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Revised Outcome Of Board Meeting Dated 05.12.2024 | Download

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Revised Outcome Of Board Meeting Dated 05.12.2024 | Download

Board Meeting 
Announced OnDec 5, 2024

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015. | Download

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015. | Download

See all events